Skip to content

ECG Nutrition and Supplements

Active
Private limited companyfounded 200620 yrs activeTruibroek 94, 3945 Tessenderlo-Ham, BelgiumKBO/BCE: BE 0880.624.792
Summary

ECG Nutrition and Supplements has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €63.72M and a net result of €2.01M. Equity is growing by ~172.2% per year across the filed fiscal years. Its solvency ranks better than 80% of 4886 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability31▼-19
Solvency99▼-1
Growth85=
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1.05M at 30 days acceptable
Liquidity ample (current ratio 1.84 against 1.73 in 2024; short-term debt: 4.2% and cash: 0.6% of total assets), and 25.8% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
74.2%
Return on assets
2.3%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 20 years 0 30 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-07-2026, 30 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
30 d early
2024
35 d early
2023
7 d early
2022
19 d early
2021
32 d early
2020
2 d early
2019
11 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
€10.56M▲ 74.3%
2024 · €6.06M
2023: €4.35Mlowest in 3 years 2024: €6.06M▲ +39.3% vs 2023 2025: €10.56M▲ +74.3% vs 2024highest in 3 years
2023 → 2025
EBIT margin
5.0%▼ 11.2pp
2024 · 16.2%
2023: 10.4% 2024: 16.2%▲ +55.0% vs 2023highest in 3 years 2025: 5.0%▼ -69.2% vs 2024lowest in 3 years
2023 → 2025
Net result
€2.01M▼ 33.0%
2024 · €3.00M
2019: €413k 2020: €269k▼ -34.7% vs 2019 2021: €401k▲ +48.7% vs 2020 2022: €-212k▼ -153% vs 2021lowest in 7 years 2023: €291k▲ +238% vs 2022 2024: €3.00M▲ +930% vs 2023highest in 7 years 2025: €2.01M▼ -33.0% vs 2024
2019 → 2025
Working capital
€3.01M▲ 189%
2024 · €1.04M
2019: €149k 2020: €420k▲ +183% vs 2019 2021: €366k▼ -13.0% vs 2020 2022: €-617k▼ -269% vs 2021 2023: €-1.57M▼ -154% vs 2022lowest in 7 years 2024: €1.04M▲ +167% vs 2023 2025: €3.01M▲ +189% vs 2024highest in 7 years
2019 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€4.35M€6.06M▲ 39.3%€10.56M▲ 74.3% 2023: €4.35Mlowest in 3 years 2024: €6.06M▲ +39.3% vs 2023 2025: €10.56M▲ +74.3% vs 2024highest in 3 years
Equity€827k-€20.83M▲ 2,420%€54.36M▲ 161%€58.72M▲ 8.0%€63.72M▲ 8.5% 2021: €827klowest in 5 years 2022: €20.83M▲ +2420% vs 2021 2023: €54.36M▲ +161% vs 2022 2024: €58.72M▲ +8.0% vs 2023 2025: €63.72M▲ +8.5% vs 2024highest in 5 years
Operating result€512k-€185k▼ 63.9%€453k▲ 145%€979k▲ 116%€525k▼ 46.4% 2021: €512k 2022: €185k▼ -63.9% vs 2021lowest in 5 years 2023: €453k▲ +145% vs 2022 2024: €979k▲ +116% vs 2023highest in 5 years 2025: €525k▼ -46.4% vs 2024
Net result€401k-€-212k€291k€3.00M▲ 930%€2.01M▼ 33.0% 2021: €401k 2022: €-212k▼ -153% vs 2021lowest in 5 years 2023: €291k▲ +238% vs 2022 2024: €3.00M▲ +930% vs 2023highest in 5 years 2025: €2.01M▼ -33.0% vs 2024
Result per fiscal year
Operating resultNet result
€-1.00M€0€1.00M€2.00M€3.00MOperating result 2021: €512k€512kNet result 2021: €401k€401kOperating result 2022: €185k€185kNet result 2022: €-212k€-212kOperating result 2023: €453k€453kNet result 2023: €291k€291kOperating result 2024: €979k€979kNet result 2024: €3.00M€3.00MOperating result 2025: €525k€525kNet result 2025: €2.01M€2.01M20212022202320242025€0€1M€2M€3MOperating result 2023: €453k€453kNet result 2023: €291k€291kOperating result 2024: €979k€979kNet result 2024: €3.00M€3MOperating result 2025: €525k€525kNet result 2025: €2.01M€2M202320242025
The operating result falls in 2025; 2025 is 46% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €85.88M
Fixed assets €79.30M ▲ 3.9%
Current assets €6.58M ▲ 166%
Equity and liabilities €85.88M
Equity €63.72M ▲ 8.5%
Debt €22.17M ▲ 10.3%
Debt's share of the balance-sheet total rises from 25.5% to 25.8%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€601k▼
2024 · €1.02M
Cash flow
€2.09M▼
2024 · €3.04M
Current ratio
1.84▲
2024 · 1.73
Quick ratio
1.73▲
2024 · 1.47
Debt to equity
0.35▲
2024 · 0.34
ROE
3.2%▼
2024 · 5.1%
ROA
2.3%▼
2024 · 3.8%
Interest coverage
0.47▼
2024 · 1.01
Debt ≤ 1 year
€3.58M▲
2024 · €1.43M
Debt > 1 year
€18.28M▼
2024 · €18.55M
Income taxes
€1k▼
2024 · €3k
Staff costs
€1.26M▲
2024 · €738k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 79 lines
Balance sheet Code20242025
Assets
Total assets20/58€78.81M€85.88M▲
Fixed assets21/28€76.34M€79.30M▲
Intangible fixed assets21€10k€96k▲
Tangible fixed assets22/27€182k€68k▼
Plant, machinery and equipment23€10k€8k▼
Furniture and vehicles24€43k€47k▲
Leasing and similar rights25€16k€10k▼
Other tangible fixed assets26€4k€3k▼
Assets under construction and advance payments27€109k-
Financial fixed assets28€76.15M€79.13M▲
Affiliated companies280/1€76.15M€79.13M▲
Participating interests280€76.15M€79.13M▲
Other financial fixed assets284/8€4k€1k▼
Amounts receivable and cash guarantees285/8€4k€1k▼
Current assets29/58€2.47M€6.58M▲
Amounts receivable after more than one year29€250k-
Trade receivables290€250k-
Stocks and contracts in progress3€365k€409k▲
Stocks30/36€365k€409k▲
Goods purchased for resale34€345k€409k▲
Advance payments36€20k-
Amounts receivable within one year40/41€1.48M€5.62M▲
Trade receivables40€1.41M€3.75M▲
Other amounts receivable41€72k€1.88M▲
Cash at bank and in hand54/58€341k€485k▲
Deferred charges and accrued income490/1€37k€65k▲
Equity and liabilities
Total equity and liabilities10/49€78.81M€85.88M▲
Equity10/15€58.72M€63.72M▲
Contributions10/11€54.83M€57.82M▲
Reserves13€3.88M€5.90M▲
Distributable reserves133€3.88M€5.90M▲
Amounts payable17/49€20.10M€22.17M▲
Amounts payable after more than one year17€18.55M€18.28M▼
Financial debts170/4€18.55M€18.28M▼
Leasing and similar obligations172€6k-
Credit institutions173€18.04M-
Other loans174€501k€18.28M▲
Amounts payable within one year42/48€1.43M€3.58M▲
Current portion of amounts payable after more than one year42€724k€10k▼
Financial debts43€1k-
Other loans439€1k-
Trade debts44€623k€3.39M▲
Suppliers440/4€623k€3.39M▲
Taxes, remuneration and social security45€81k€176k▲
Taxes450/3€3k€38k▲
Remuneration and social security454/9€79k€138k▲
Accrued charges and deferred income492/3€122k€315k▲
Income statement Code20242025
Operating income70/76A€6.07M€10.58M▲
Turnover70€6.06M€10.56M▲
Other operating income74€13k€19k▲
Operating charges60/66A€5.09M€10.05M▲
Goods for resale, raw materials and consumables60€2.10M€2.32M▲
Purchases600/8€2.15M€2.36M▲
Change in stocks: decrease (increase)609€-45k€-44k▲
Services and other goods61€2.20M€6.38M▲
Remuneration, social security and pensions62€738k€1.26M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€42k€76k▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€4k€1k▼
Other operating charges640/8€6k€11k▲
Operating profit (loss)9901€979k€525k▼
Financial income75/76B€3.15M€3.04M▼
Recurring financial income75€3.15M€3.02M▼
Income from financial fixed assets750€3.14M€3.00M▼
Other financial income752/9€4k€22k▲
Non-recurring financial income76B€849€12k▲
Financial charges65/66B€1.12M€1.55M▲
Recurring financial charges65€1.12M€1.30M▲
Debt charges650€1.01M€1.28M▲
Other financial charges652/9€114k€21k▼
Non-recurring financial charges66B-€250k
Profit (loss) for the period before taxes9903€3.01M€2.01M▼
Income taxes67/77€3k€1k▼
Taxes670/3€3k€1k▼
Profit (loss) for the period9904€3.00M€2.01M▼
Profit (loss) for the period to be appropriated9905€3.00M€2.01M▼
Appropriation of the result
Profit (loss) to be appropriated9906€3.00M€2.01M▼
Transfer to equity691/2€3.00M€2.01M▼
To other reserves6921€3.00M€2.01M▼
Social balance
Average headcount (FTE)90879.012.5▲

The notes to these accounts (76 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement
Line20212022202320242025Change
Operating income70/76A--€4.36M€6.07M€10.58M▲ 74.2%
Turnover70--€4.35M€6.06M€10.56M▲ 74.3%
Other operating income74--€10k€13k€19k▲ 51.8%
Non-recurring operating income76A€890-----
Operating charges60/66A--€3.90M€5.09M€10.05M▲ 97.4%
Goods for resale, raw materials and consumables60--€1.57M€2.10M€2.32M▲ 10.3%
Purchases600/8--€1.66M€2.15M€2.36M▲ 10.1%
Change in stocks: decrease (increase)609--€-86k€-45k€-44k▲ 1.3%
Services and other goods61--€1.98M€2.20M€6.38M▲ 190%
Remuneration, social security and pensions62€147k€163k€303k€738k€1.26M▲ 71.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8k€25k€39k€42k€76k▲ 81.5%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€853€3k€4k€1k▼ 61.1%
Other operating charges640/8€2k€1k€4k€6k€11k▲ 80.0%
Non-recurring operating charges66A-€2k€2k---
Gross operating margin9900€669k€377k----
Operating profit (loss)9901€512k€185k€453k€979k€525k▼ 46.4%
Financial income75/76B€23k€51k€640k€3.15M€3.04M▼ 3.6%
Recurring financial income75€23k€50k€640k€3.15M€3.02M▼ 4.0%
Income from financial fixed assets750--€639k€3.14M€3.00M▼ 4.5%
Other financial income752/9--€729€4k€22k▲ 453%
Non-recurring financial income76B-€792-€849€12k▲ 1,341%
Financial charges65/66B€6k€448k€801k€1.12M€1.55M▲ 37.9%
Recurring financial charges65€6k€448k€801k€1.12M€1.30M▲ 15.6%
Debt charges650--€680k€1.01M€1.28M▲ 26.6%
Other financial charges652/9--€121k€114k€21k▼ 81.4%
Non-recurring financial charges66B----€250k-
Profit (loss) for the period before taxes9903€529k€-212k€292k€3.01M€2.01M▼ 33.0%
Income taxes67/77€129k-€411€3k€1k▼ 65.4%
Taxes670/3--€411€3k€1k▼ 65.4%
Profit (loss) for the period9904€401k€-212k€291k€3.00M€2.01M▼ 33.0%
Profit (loss) for the period to be appropriated9905€401k€-212k€291k€3.00M€2.01M▼ 33.0%
Line20212022202320242025Change
Assets
Total assets20/58€1.11M€34.07M€70.88M€78.81M€85.88M▲ 9.0%
Fixed assets21/28€465k€33.13M€68.61M€76.34M€79.30M▲ 3.9%
Intangible fixed assets21€38k€35k€28k€10k€96k▲ 834%
Tangible fixed assets22/27€5k€84k€83k€182k€68k▼ 62.6%
Plant, machinery and equipment23-€13k€14k€10k€8k▼ 25.9%
Furniture and vehicles24€3k€38k€42k€43k€47k▲ 10.8%
Leasing and similar rights25-€28k€22k€16k€10k▼ 35.7%
Other tangible fixed assets26€2k€5k€5k€4k€3k▼ 35.6%
Assets under construction and advance payments27---€109k--
Financial fixed assets28€422k€33.01M€68.50M€76.15M€79.13M▲ 3.9%
Affiliated companies280/1--€68.50M€76.15M€79.13M▲ 3.9%
Participating interests280--€66.73M€76.15M€79.13M▲ 3.9%
Amounts receivable281--€1.76M---
Other financial fixed assets284/8--€1k€4k€1k▼ 68.5%
Amounts receivable and cash guarantees285/8--€1k€4k€1k▼ 68.5%
Current assets29/58€645k€933k€2.27M€2.47M€6.58M▲ 166%
Amounts receivable after more than one year29--€150k€250k--
Trade receivables290--€150k€250k--
Stocks and contracts in progress3€167k€215k€301k€365k€409k▲ 12.0%
Stocks30/36€167k€215k€301k€365k€409k▲ 12.0%
Goods purchased for resale34--€301k€345k€409k▲ 18.6%
Advance payments36---€20k--
Amounts receivable within one year40/41€107k€284k€1.41M€1.48M€5.62M▲ 281%
Trade receivables40€91k€170k€1.39M€1.41M€3.75M▲ 167%
Other amounts receivable41€16k€114k€24k€72k€1.88M▲ 2,515%
Cash at bank and in hand54/58€356k€382k€242k€341k€485k▲ 42.1%
Deferred charges and accrued income490/1€15k€52k€161k€37k€65k▲ 74.9%
Equity and liabilities
Total equity and liabilities10/49€1.11M€34.07M€70.88M€78.81M€85.88M▲ 9.0%
Equity10/15€827k€20.83M€54.36M€58.72M€63.72M▲ 8.5%
Contributions10/11€24k€20.24M€53.48M€54.83M€57.82M▲ 5.4%
Reserves13€803k€591k€882k€3.88M€5.90M▲ 51.8%
Distributable reserves133€803k€591k€882k€3.88M€5.90M▲ 51.8%
Amounts payable17/49€283k€13.23M€16.51M€20.10M€22.17M▲ 10.3%
Amounts payable after more than one year17-€11.43M€12.41M€18.55M€18.28M▼ 1.5%
Financial debts170/4-€11.43M€12.41M€18.55M€18.28M▼ 1.5%
Leasing and similar obligations172--€13k€6k--
Credit institutions173--€12.39M€18.04M--
Other loans174---€501k€18.28M▲ 3,547%
Amounts payable within one year42/48€279k€1.55M€3.83M€1.43M€3.58M▲ 150%
Current portion of amounts payable after more than one year42-€728k€723k€724k€10k▼ 98.6%
Financial debts43-€750k€750k€1k--
Credit institutions430/8-€750k€750k---
Other loans439---€1k--
Trade debts44€263k€26k€903k€623k€3.39M▲ 444%
Suppliers440/4€263k€26k€903k€623k€3.39M▲ 444%
Taxes, remuneration and social security45€16k€46k€56k€81k€176k▲ 117%
Taxes450/3€4k€10k€11k€3k€38k▲ 1,371%
Remuneration and social security454/9€12k€36k€45k€79k€138k▲ 75.4%
Other amounts payable47/48--€1.40M---
Accrued charges and deferred income492/3€4k€253k€274k€122k€315k▲ 158%
Line20212022202320242025Change
Profit (loss) for the period9904€401k€-212k€291k€3.00M€2.01M▼ 33.0%
+ Depreciation and write-downs630€8k€25k€39k€42k€76k▲ 81.5%
Operating cash flow (approximation)€408k€-187k€330k€3.04M€2.09M▼ 31.4%
Investment in fixed assets (approximation)-€-32.69M€-35.51M€-7.78M€-3.03M▲ 61.0%
Change in cash-€26k€-140k€99k€144k▲ 44.6%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Sign in to download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
20-07
State Gazette act Appointment: EQUOR SASU (director)
Permanent representative: Sebastien Boussemart3 facts ▸
  • General meeting, 03-06-2026
  • Director appointment, EQUOR SASU (director)
  • Permanent representative, Sebastien Boussemart
01-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
13-03
State Gazette act Statutes amendment
Capital · Power of attorney · Corporate power5 facts ▸
  • General meeting, 06-03-2026
  • Statutes amendment
  • Capital
  • Power of attorney
  • Corporate power, De vennootschap kan persoonlijke of zakelijke borgen stellen in het voordeel van derden
06-01
State Gazette act Resignations: Robertus Falk, Laurence Masterson and 2 others
Permanent representatives: Tom Mariën, Jonathan Mommer and Julie Santens · Appointments: T&K Partners BV (director) and KAFINCO BV (director)11 facts ▸
  • General meeting, 15-10-2025
  • Director resignation, Robertus Falk (director)
  • Director resignation, Laurence Masterson (director)
  • Director resignation, SHATAL BV (director)
  • Director resignation, Equine Care Group NV (director)
  • Permanent representative, Tom Mariën
  • Permanent representative, Jonathan Mommer
  • Permanent representative, Julie Santens
  • Permanent representative, Tom Mariën
  • Director appointment, T&K Partners BV (director)
  • Director appointment, KAFINCO BV (director)
2025
28-10
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital8 facts ▸
  • General meeting, 14-10-2025
  • Capital increase, €2.986.251,72
  • Share issue, 2450512, EUR
  • Statutes amendment
  • Capital
  • Condition precedent, inbreng in natura pas kan plaatsvinden nadat de inbreng van aandelen van Thoroughbred Remedies Manufacturing Limited in ECG N&S Ireland LtD door Valentine Georg…
  • Power of attorney, ECG Nutrition and Supplements
  • Power of attorney, ECG Nutrition and Supplements
26-06
NBB filing Annual accounts filed
fiscal year 2024 · full schema
05-05
State Gazette act Statutes amendment
Power of attorney · Governance decision4 facts ▸
  • General meeting, 08-04-2025
  • Statutes amendment
  • Power of attorney, ECG Nutrition and Supplements
  • Governance decision, Machten aan het bestuursorgaan
2024
31-12
Financial Highest result since 2019net €3.00M ▲930%
Operating result €979k, net result €3.00M, both a record.
31-12
Financial Liquidity triplescurrent ratio 1.73
Current ratio from 0.59 to 1.73; short-term debt falls from €3.83M to €1.43M.
17-12
State Gazette act Capital & shares
Capital increase · Share issue · Statutes amendment8 facts ▸
  • General meeting, 03-12-2024
  • Capital increase, €499.999,61
  • Share issue, volledig gestorte aandelen, 911678
  • Statutes amendment
  • Capital
  • Inbreng in natura, zeker, vaststaande en opeisbare schuldvordering ten laste van de Vennootschap
  • Profit sharing, pro rata temporis vanaf de inschrijving
  • Condition precedent, de onderhavige transactie pas kan plaatsvinden na de effectieve doorgang van de acquisitie
21-10
State Gazette act Appointment: BDO Bedrijfsrevisoren BV (statutory auditor)
Permanent representatives: Michel Dupont and Gert Maris4 facts ▸
  • General meeting, 26-09-2024
  • Auditor appointment, BDO Bedrijfsrevisoren BV (statutory auditor)
  • Permanent representative, Michel Dupont
  • Permanent representative, Gert Maris
11-10
State Gazette act Statutes amendment
Capital increase · Share issue · Power of attorney5 facts ▸
  • General meeting, 01-10-2024
  • Capital increase, €499.999,61
  • Share issue, 911678, 128543006
  • Statutes amendment
  • Power of attorney
Show earlier events
24-07
NBB filing Annual accounts filed
fiscal year 2023 · full schema
26-04
State Gazette act Resignation: Jeroen Geldhof (director)
2 facts ▸
  • General meeting, 22-03-2024
  • Director resignation, Jeroen Geldhof (director)
12-04
State Gazette act Miscellaneous
Share issue · Power of attorney · Waiver5 facts ▸
  • General meeting, 27-03-2024
  • Share issue, Inschrijvingsrechten, 2500000
  • Power of attorney, Bestuursorgaan
  • Waiver, afstand van het voorkeurrecht
  • Power of attorney, Bestuursorgaan
07-03
State Gazette act Statutes amendment
Capital increase · Share issue · Capital9 facts ▸
  • General meeting, 22-02-2024
  • Capital increase, €349.999,8
  • Share issue, 827511
  • Statutes amendment
  • Capital
  • Power of attorney, ECG Nutrition and Supplements
  • Board powers, Machten aan het bestuursorgaan
  • Auditor report, 19-02-2024, 18-01-2024
  • Condition, transactie kan pas plaatsvinden na de effectieve doorgang van de acquisitie
2023
31-12
Financial Back to profitnet €291k
Net result €291k after one loss-making year.
31-12
Financial Equity above €50MEq €54.36M ▲161%
Equity rises from €20.83M to €54.36M.
27-12
State Gazette act Resignation: JOCA (director and day-to-day manager)
Appointments: Equine Care Group, GELDHOF Jeroen and 2 others · Permanent representative: MOMMER Jonathan · Capital increase16 facts ▸
  • General meeting, 06-12-2023
  • Capital increase, €6.249.999,72
  • Capital
  • Statutes amendment
  • Director resignation, JOCA (director and day-to-day manager)
  • Director appointment, Equine Care Group (director)
  • Permanent representative, MOMMER Jonathan
  • Director appointment, GELDHOF Jeroen (director)
  • Director appointment, FALK Robertus Johannes (director)
  • Director appointment, MASTERSON Laurence Eugene (director)
  • Mandate compensation, Equine Care Group
  • Mandate compensation, GELDHOF Jeroen
  • +4 further facts in this act
20-12
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Power of attorney10 facts ▸
  • General meeting, 06-12-2023
  • Capital increase, €24.280.833,1
  • Capital increase, €2.228.569,45
  • Statutes amendment
  • Capital
  • Power of attorney
  • Preemption waiver, Afstand van het voorkeurrecht
  • Inbreng in natura detail, Inbreng in natura van een schuldvordering die de aandeelhouder ten laste van de Vennootschap heeft
  • Share price, 0.422954859205138, EUR
  • Share payment condition, 0% storting op de nieuwe aandelen, in afwijking van artikel 5:125 WVV, zonder geblokkeerde rekening
12-12
State Gazette act Resignation: Haras du Reverdy SaS (director)
Permanent representative: Eric Lecler3 facts ▸
  • General meeting, 27-11-2023
  • Director resignation, Haras du Reverdy SaS (director)
  • Permanent representative, Eric Lecler
02-08
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Power of attorney5 facts ▸
  • General meeting, 25-07-2023
  • Capital increase, €479.275,18
  • Statutes amendment
  • Capital
  • Power of attorney, ECG Nutrition and Supplements
12-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial Weakest financial yearnet €-212k
Net result drops to €-212k, the lowest in the series; recovery starts the following year.
31-12
Financial Equity above €10MEq €20.83M ▲2,420%
Equity rises from €827k to €20.83M.
10-10
State Gazette act Appointment: Haras du Reverdy (director)
Permanent representative: LECLER Eric Lucien Paul · Share issue · Capital contribution11 facts ▸
  • General meeting, 29-09-2022
  • Share issue, 3849078, inbreng in natura
  • Capital contribution
  • Capital contribution
  • Capital
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Director appointment, Haras du Reverdy (director)
  • Permanent representative, LECLER Eric Lucien Paul
  • Mandate compensation, Haras du Reverdy
05-10
State Gazette act Capital & shares · Statutes amendment
Share issue · Power of attorney8 facts ▸
  • General meeting, 28-09-2022
  • Share issue, 17670772, inbreng in geld
  • Statutes amendment
  • Resolution, Afstand van de uitgifteverslaggeving
  • Resolution, Individuele afstand van het voorkeurrecht
  • Power of attorney
  • Power of attorney
  • Power of attorney
03-10
State Gazette act Capital & shares · Statutes amendment
Share issue · Capital · Power of attorney9 facts ▸
  • General meeting, 23-09-2022
  • Share issue, 3422477, inbreng in geld
  • Capital
  • Statutes amendment
  • Resolution, Afstand van de uitgifteverslaggeving
  • Resolution, Individuele afstand van het voorkeurrecht
  • Power of attorney
  • Power of attorney
  • Power of attorney
26-08
State Gazette act Capital & shares · Statutes amendment
Reserve release · Capital increase · Share issue8 facts ▸
  • General meeting, 18-08-2022
  • Reserve release, Omvorming van de (statutaire) onbeschikbare eigen vermogensrekening in een beschikbare eigen vermogensrekening
  • Capital increase, €300.846,46
  • Share issue, 636053, 0.47
  • Capital
  • Statutes amendment
  • Preemption waiver, Afstand van het voorkeurrecht
  • Power of attorney
12-07
State Gazette act Permanent representatives: Michel Dupont and Gert Maris
Appointment: BDO Bedrijfsrevisoren BV (director) · Mandate end5 facts ▸
  • Board meeting, 15-10-2021
  • Permanent representative, Michel Dupont
  • Permanent representative, Gert Maris
  • Director appointment, BDO Bedrijfsrevisoren BV
  • Mandate end, onmiddellijk na de gewone algemene vergadering die zich zal uitspreken over de goedkeuring van de jaarrekening van het boekjaar eindigend op 31 december 2023
29-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
09-03
State Gazette act Capital & shares
Capital increase · Share issue · Statutes amendment5 facts ▸
  • General meeting, 25-02-2022
  • Capital increase, €6.000.002,88
  • Share issue, 12685274, EQUINE CARE GROUP
  • Statutes amendment
  • Power of attorney, KMG Boekhouding
2021
31-12
Financial Equity above €500kEq €827k ▲94%
3 profitable years in a row build equity to €827k.
16-12
State Gazette act Registered office
Registered-office move2 facts ▸
  • General meeting, 04-11-2021
  • Registered-office move, 3945 Ham, Truibroek 94/10
10-09
State Gazette act Capital & shares
Name change · Share split · Power of attorney4 facts ▸
  • General meeting, 30-08-2021
  • Name change, ECG Nutrition and Supplements
  • Share split, split, 41667
  • Power of attorney, KMG Boekhouding
06-04
State Gazette act Appointments: BDO Bedrijfsrevisoren (statutory auditor) and JOCA BV (day-to-day manager)
Permanent representative: Joseph Gijbels5 facts ▸
  • General meeting, 02-02-2021
  • Auditor appointment, BDO Bedrijfsrevisoren (statutory auditor)
  • Board meeting, 02-02-2021
  • Director appointment, JOCA BV (day-to-day manager)
  • Permanent representative, Joseph Gijbels
22-02
State Gazette act Resignations: TOMSON IMMO (manager) and JOCA (manager)
Reappointments: TOMSON IMMO (non-statutory director) and JOCA (non-statutory director) · Statutes amendment · Reserve release15 facts ▸
  • General meeting, 02-02-2021
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Reserve release, Statutair onbeschikbare eigen vermogensrekening opgeheven en middelen beschikbaar gemaakt voor uitkering
  • Capital conversion, Gecombineerd werkelijk gestort kapitaal en wettelijke reserve, omgezet in statutair onbeschikbare eigen vermogensrekening
  • Director resignation, TOMSON IMMO (manager)
  • Director resignation, JOCA (manager)
  • Director reappointment, TOMSON IMMO (non-statutory director)
  • Director reappointment, JOCA (non-statutory director)
  • Director discharge, TOMSON IMMO
  • Director discharge, JOCA
  • +3 further facts in this act
29-01
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-06
Financial Equity above €200kEq €426k ▲172%
2 profitable years in a row build equity to €426k.
20-01
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
25-01
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
17-01
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
20-01
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
2011
10-02
State Gazette act Resignation: Joseph GIJBELS (manager)
Appointments: BVBA TOMSON IMMO (manager) and Comm.V. JOCA (manager) · Permanent representatives: Tom MARIËN and Joseph GIJBELS · Number of directors7 facts ▸
  • General meeting, 01-10-2010
  • Director resignation, Joseph GIJBELS (manager)
  • Director appointment, BVBA TOMSON IMMO (manager)
  • Director appointment, Comm.V. JOCA (manager)
  • Permanent representative, Tom MARIËN
  • Permanent representative, Joseph GIJBELS
  • Number of directors, 2
2010
17-03
State Gazette act Resignation: Sonja GROOTJANS (manager)
2 facts ▸
  • General meeting, 10-09-2009
  • Director resignation, Sonja GROOTJANS (manager)
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
27 of 27 acts read

Directors · office · real estate

Directors
11 directors, no change since 2026
EQUOR SASU
Director · since 03-06-2026 · Legal entity · perm. rep.: Sebastien Boussemart
Current
KAFINCO
Director · since 15-10-2025 · Private limited company · perm. rep.: Julie Santens
Current
T&K Partners
Director · since 15-10-2025 · Private limited company · perm. rep.: Tom Mariën
Current
Equine Care Group
Director · since 06-12-2023 · Legal entity · perm. rep.: MOMMER Jonathan
Current
Haras du Reverdy
Director · since 30-09-2022 · Legal entity · perm. rep.: LECLER Eric Lucien Paul
Current
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
Director · since 04-07-2022 · Private limited company
Current
5 other directors
JOCA BV
Day-to-day manager · since 02-02-2021 · Legal entity · perm. rep.: Joseph Gijbels
Current
Joca
Non-statutory director · Legal entity
Current
TOMSON IMMO
Non-statutory director · Legal entity
Current
BVBA TOMSON IMMO
Manager · since 01-10-2010 · Legal entity · perm. rep.: Tom MARIËN
Not recently confirmed
Comm.V. JOCA
Manager · since 01-10-2010 · Legal entity · perm. rep.: Joseph GIJBELS
Not recently confirmed
03-06-2026 EQUOR SASU: Appointed as Director
15-10-2025 KAFINCO: Appointed as Director
15-10-2025 T&K Partners: Appointed as Director
15-10-2025 EQUINE CARE GROUP: Resigned as Director
15-10-2025 FALK Robertus Johannes: Resigned as Director
Full history in the Timeline (23 changes) →
Location & real-estate footprint
Registered office, Tessenderlo-Ham · 1 establishment unit since 2021
seat establishment The establishment unit on the map
Ground area
1.2 ha
Building footprint
393 m²
Volume, LiDAR
5,684 m³
Parcel 71046B0788/00W003, Flanders · tallest building 22.9 m, ±6 floors. Linked by address, not a title deed.
16 companies at this address See who is registered here
1 establishment unit
ECG Nutrition and Supplements
Truibroek 94, 3945 HamAgents in non-specialised wholesale trade
since 20212.324.662.903
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71046B0788/00W003 Flanders 1.2 ha 1 · 393 m² 22.9 m · 6 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISESCurrent
Statutory auditor
02-02-2021 → present

Articles of association

Purpose
Het fabriceren van drogisterijproducten, verzorgingsproducten, cosmetica, medisch en paramedisch materiaal, dieetproducten, vitaminepreparaten, voedingssupplementen en aanverwante…
Full purpose

Het fabriceren van drogisterijproducten, verzorgingsproducten, cosmetica, medisch en paramedisch materiaal, dieetproducten, vitaminepreparaten, voedingssupplementen en aanverwante medische producten, homeopathische producten en dergelijke; Het commercialiseren, onder al zijn mogelijke vormen, en met name de aankoop, de verkoop, de groothandel, de kleinhandel, de import, de export, de makelaardij en de commissie van om het even welke producten en goederen, onder andere de hoger vermelde; Het uitbaten van para-pharmacies; Het onderzoek, het ontwikkelen, het vervaardigen en/of het commercialiseren van nieuwe producten, nieuwe vormen van technologie en hun toepassingen; Consultancy, opleiding, technische expertise en bijstand op voornoemde gebieden; Het aanleggen, oordeelkundig uitbouwen en beheren van een onroerend vermogen, alle verrichtingen met betrekking tot onroerende goederen en onroerende zakelijke rechten zoals de huurfinanciering van onroerende goederen aan derden, het aankopen, verkopen, ruilen, bouwen, verbouwen, onderhouden, verhuren, huren, verkavelen, prospecteren en uitbaten van onroerende goederen; de vennootschap mag tevens de bedrijvigheden coördineren die betrekking hebben op de gehele en gedeeltelijke uitvoering van voltooiingswerken door onderaannemers; Het aanleggen, oordeelkundig uitbouwen en beheren van een roerend vermogen, alle verrichtingen met betrekking tot roerende goederen en rechten, van welke aard ook zoals het verwerven door inschrijving of aankoop en het beheren van aandelen, obligaties, kasbons of andere roerende waarden, van welke vorm ook, van Belgische of buitenlandse, bestaande of nog op te richten rechtspersonen en ondernemingen.

Structure & network

Connections & network

12 connected companies
Depth
+7 companies via a shared corporate director +7via a sharedcorporate directorDEFINCO, Shared corporate director DDEFINCODEWULF, Shared corporate director DDEWULFECG Clinics, Shared corporate director ECECG ClinicsECG Labs, Shared corporate director ELECG LabsHELIVENTURE FTO, Shared corporate director HFHELIVENTUREFTOECG Nutrition and Supplements ECGNutrition…0880.624.792
Shared directorsBundled connections
This company Company Director Shareholding Click a node to look further, drag to arrange, scroll to zoom.
Linked via shared directors
AQUAFIN
Shared corporate director
→
DEFINCO
Shared corporate director
→
DEHOLI
Shared corporate director
→
DEMOCO
Shared corporate director
→
Show 8 more companies with a shared director
DEWULF
Shared corporate director
→
ECG Clinics
Shared corporate director
→
ECG Labs
Shared corporate director
→
HELIVENTURE FTO
Shared corporate director
→
Lalemant
Shared corporate director
→
MELEXIS
Shared corporate director
→
NORRIQ Belgium
Shared corporate director
→

Capital and shareholders

Shareholders according to the acts
  • Haras du Reverdy
  • Biovet ApS

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 13-03-2026 Capital stated in the act · 131,905,196 shares
  2. 28-10-2025 Capital increase of 2,986,251.72 EUR · 2,450,512 new shares
  3. 17-12-2024 Capital increase of 499,999.61 EUR · 911,678 new shares · in kind
  4. 11-10-2024 Capital increase of 499,999.61 EUR · 911,678 new shares · in kind
  5. 07-03-2024 Capital increase of 349,999.80 EUR · 827,511 new shares · in kind
  6. 27-12-2023 Capital increase of 6,249,999.72 EUR · 14,776,990 new shares · in kind
  7. 20-12-2023 Capital increase of 24,280,833.10 EUR · 57,407,623 new shares
  8. 20-12-2023 Capital increase of 2,228,569.45 EUR · 5,269,048 new shares
Show 6 older capital entries
  1. 02-08-2023 Capital increase of 479,275.18 EUR · 1,086,422 new shares
  2. 10-10-2022 Capital stated in the act · 48,263,734 shares
  3. 03-10-2022 Capital stated in the act · 26,743,884 shares
  4. 26-08-2022 Capital increase of 300,846.46 EUR · 636,053 new shares
  5. 09-03-2022 Capital increase of 6,000,002.88 EUR · to 6,024,002.88 EUR · 12,685,274 new shares
  6. 22-02-2021 Capital conversion · 26,400 EUR

Recognitions · licences · registrations

Food safety, FASFC

1 site
Ham2.324.662.903
2 permissions
Toelating · Groothandelaar levensmiddelen · since 08-02-2022
Toelating · Groothandelaar mengvoeders · since 08-02-2022

Legal Entity Identifier

894500BQNIMND6BQLW94
live in the LEI register

Similar companies · same sector, comparable size

Of 1,423 companies in sector 46389 we hold annual accounts for 853. 58 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded10-04-2006
Fiscal year end31-12
Activities, NACEBEL 2025
46389Wholesale of other food products
46450Wholesale of perfume and cosmetics
46170Agents in the wholesale of food, beverages and tobacco

Scores and ratios are computed by Checked and are not a credit decision.